| http://www.w3.org/ns/prov#value | - The peptide ligand of claim 1, wherein the amino acid sequence consists of: Xaa(1-7)-Cys-Xaa9-Gly-Cys-Xaa(14-20) (SEQ ID NO:92), wherein Xaa(1-7) is absent or between one and seven amino acids; and Xaa9 is an amino acid selected from the group consisting of Met, Ile, Thy, or Cys; and Xaa(14-20) is absent or between one and seven amino acids.
|
